• Okadaic acid (A4540): Protocols for PP1/PP2A Inhibition Stud

  2026-05-21

  Okadaic acid is a nanomolar-range marine inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), enabling precise modulation of phosphorylation-dependent signaling pathways. It is best suited for apoptosis assays, signal transduction studies, and cancer research, but should be avoided in workflows sensitive to off-target phosphatase effects or solvent interference.

• Amitriptyline HCl: Technical Guide for Neuropharmacology Res

  2026-05-21

  Amitriptyline HCl (SKU B2231) is a validated tricyclic compound for precise neurotransmitter receptor modulation, providing robust performance in neuropharmacology and mood disorder research. It is best suited for in vitro and ex vivo workflows requiring accurate serotonin/norepinephrine receptor inhibition, but is not appropriate for long-term solution storage or applications outside its defined receptor profile.

• Baicalin Methyl Ester: Applied Workflows for Gut Barrier Rep

  2026-05-20

  Baicalin methyl ester, a next-generation esterified derivative of baicalin, offers targeted modulation of the intestinal barrier through the P65/TNF-α/MLCK/ZO-1 pathway. This article details experimental protocols, troubleshooting strategies, and advanced applications, positioning APExBIO's product as a gold standard for LPS-induced intestinal barrier damage research.

• Experimental Guidance for Cathepsin B Inhibitor CA-074 (A192

  2026-05-20

  Cathepsin B inhibitor CA-074 provides researchers with a highly selective, nanomolar-potency tool for dissecting cathepsin B’s role in cancer metastasis, neurodegeneration, and immune regulation. It is best suited for biochemical, cell-based, and in vivo studies requiring precise inhibition of cathepsin B with minimal off-target effects. Researchers should avoid use in assays where cathepsin H or L inhibition is required, or when long-term solution stability is essential.

• Tobramycin: Optimizing Gram-Negative Antibiotic Assays in Re

  2026-05-19

  Tobramycin, a potent aminoglycoside antibiotic, delivers unmatched precision for microbiology research targeting Gram-negative pathogens. Discover how its high purity, water solubility, and data-backed efficacy enable advanced workflows, robust resistance profiling, and troubleshooting excellence.

• Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) in Co

  2026-05-19

  Ibuprofen is more than a classic NSAID—its dual COX inhibition and anti-proliferative properties make it a versatile tool in colon cancer workflows. Discover how APExBIO’s Ibuprofen powers apoptosis induction, cell cycle arrest assays, and advanced troubleshooting for robust, reproducible results.

• MOG (35-55) Peptide: Precision Tools for Autoimmune Encephal

  2026-05-18

  Leverage the MOG (35-55) myelin oligodendrocyte glycoprotein peptide to create robust, reproducible models of neuroinflammation and multiple sclerosis. This guide delivers workflow enhancements, troubleshooting strategies, and data-backed protocol parameters to maximize reliability in autoimmune encephalomyelitis research.

• FITC-Concanavalin A (ConA) Conjugate: Technical Usage Guide

  2026-05-18

  FITC-Concanavalin A (ConA) Conjugate enables targeted, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting workflows in immunofluorescence staining and flow cytometry. This reagent should not be used outside carbohydrate-binding applications or beyond its defined storage and stability parameters.

• Bortezomib (PS-341): Benchmarks and Mechanisms in Proteasome

  2026-05-17

  Bortezomib (PS-341) is a potent, reversible 20S proteasome inhibitor used extensively in multiple myeloma and mantle cell lymphoma research. This article details its mechanistic basis, quantitative performance in apoptosis assays, and clarifies its best practices and limitations for research workflows.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Protocol &

  2026-05-16

  The PKH26 Red Fluorescent Cell Linker Kit enables stable, membrane-specific labeling for cell tracing and proliferation detection in both in vitro and in vivo research. It is not suitable for intracellular labeling or non-membrane targets, and optimal use requires strict adherence to protocol parameters for reproducibility and minimal toxicity.

• Maternal IL-17A as a Prognostic Biomarker in GBS Colonizatio

  2026-05-15

  This study identifies low maternal IL-17A levels as a significant prognostic biomarker for the risk of invasive neonatal disease in pregnancies with Group B Streptococcus (GBS) colonization. By integrating clinical cohort data with ex vivo TLR1/2 stimulation, it advances understanding of perinatal immune mechanisms and informs risk assessment strategies.

• Chronic E-64 Cathepsin Inhibition in Salt-Sensitive Hyperten

  2026-05-15

  This study evaluates the impact of chronic inhibition of cysteine cathepsins by E-64 in Dahl salt-sensitive rats, a model for salt-induced hypertension and kidney damage. The findings reveal that systemic cathepsin inhibition with E-64 does not alter blood pressure or kidney injury outcomes, highlighting limitations in targeting cysteine proteases for this particular pathophysiological context.

• Technical Guide: EdU Imaging Kits (HF594) for S-phase Detect

  2026-05-14

  EdU Imaging Kits (HF594) offer a robust method for quantifying cell proliferation by directly labeling DNA synthesis using 5-ethynyl-2’-deoxyuridine and click chemistry. These kits circumvent the harsh denaturation and antibody steps of BrdU assays, providing sensitive, low-background detection in fixed-cell workflows. Not suitable for live-cell or non-fixed applications due to fixation requirements.

• Sulfaphenazole: CYP2C9 Inhibitor for Vascular and Wound Rese

  2026-05-14

  Sulfaphenazole, a selective CYP2C9 inhibitor, offers robust and reproducible workflows for vascular function, oxidative stress, and wound healing studies—now proven to reduce pressure and thermal injury severity in translational models. Its unique dual action in both drug metabolism modulation and antimicrobial activity positions it as a cornerstone reagent for researchers seeking precise, data-driven results.

• Okadaic Acid: Technical Guide for PP1/PP2A Inhibition Assays

  2026-05-13

  Okadaic acid is a marine-derived inhibitor used for selective suppression of protein phosphatase 1 (PP1) and 2A (PP2A) activity in biochemical and cell signaling studies. Researchers employ it to dissect phosphorylation-dependent pathways and induce apoptosis in cellular systems. It is not recommended for studies requiring broad-spectrum phosphatase inhibition or in workflows where its strong potency may confound off-target effects.

16273 records 1/1085 page Next 12345 下5页 Last page